LBF20406AM13: Difference between revisions

No edit summary
 
No edit summary
 
(17 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}


Line 4: Line 6:
|LipidBank=XPR7029
|LipidBank=XPR7029
|LipidMaps=LMFA08020015
|LipidMaps=LMFA08020015
|SysName=N- (1,1-dimethylpropyl) arachidonoyl amide
|SysName=N- (1,1-Dimethylpropyl)- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine
|Melting Point=colorless oil <<7001>>
|Common Name=&&N- (1,1-Dimethylpropyl)arachidonoylamide&&N- (1,1-Dimethylpropyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine&&
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H NMR (CDCl3) <FONT FACE="Symbol">d</FONT>5.28-5.38 (m, 8H), 5.10 (br s, lH), 2.67-2.82 (m, 6H), 2.04-2.12 (m, 6H), 1.66-1.76 (m, 4H), 1.24-1.32 (m, l2 H), 0.81-0.90 (m, 6H). <<7001>>
|Melting Point=colorless oil [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|NMR Spectra=^1 H NMR (CDCl3) delta 5.28-5.38 (m, 8H), 5.10 (br s, lH), 2.67-2.82 (m, 6H), 2.04-2.12 (m, 6H), 1.66-1.76 (m, 4H), 1.24-1.32 (m, l2 H), 0.81-0.90 (m, 6H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|Source=
|Chemical Synthesis=This compound was synthesized from arachidonoyl chloride and 1,1-dimethylpropylamine.Yield 58 % [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|Metabolism=
|Biological Activity=Binding of this compound to the brain cannabinoid receptor (CBl),Ki(nM)= 446.7±40.3 [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
}}
}}
{{Lipid/Footer}}

Latest revision as of 04:42, 21 October 2010

LipidBank Top
(トップ) 		Fatty acid
(脂肪酸) 		Glycerolipid
(グリセロ脂質) 		Sphingolipid
(スフィンゴ脂質) 		Journals
(雑誌一覧) 		How to edit
(ページの書き方)


Upper classes: LB LBF



IDs and Links
LipidBank XPR7029
LipidMaps LMFA08020015
CAS
KEGG {{{KEGG}}}
KNApSAcK {{{KNApSAcK}}}
mol LBF20406AM13
N- (1,1-Dimethylpropyl)arachidonoylamide
LBF20406AM13.png
Structural Information
N- (1,1-Dimethylpropyl)- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine
  • N- (1,1-Dimethylpropyl)arachidonoylamide
  • N- (1,1-Dimethylpropyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine
Formula C25H43NO
Exact Mass 373.334465003
Average Mass 373.61505999999997
SMILES C(NC(C)(C)CC)(=O)CCCC=CCC=CCC=CCC=CCCCCC
Physicochemical Information
colorless oil Sheskin_T et al.
This compound was synthesized from arachidonoyl chloride and 1,1-dimethylpropylamine.Yield 58 % Sheskin_T et al.
Binding of this compound to the brain cannabinoid receptor (CBl),Ki(nM)= 446.7±40.3 Sheskin_T et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra 1H NMR (CDCl3) δ 5.28-5.38 (m, 8H), 5.10 (br s, lH), 2.67-2.82 (m, 6H), 2.04-2.12 (m, 6H), 1.66-1.76 (m, 4H), 1.24-1.32 (m, l2 H), 0.81-0.90 (m, 6H). SheskinTet al.
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20406AM13 See above. Sheskin_T et al. 1997


Retrieved from "http://lipidbank.jp/mediawiki/index.php?title=LBF20406AM13&oldid=54476"